(Q37146664)
Statements
CD44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virus-positive patients with resected hepatocellular carcinoma (English)
Anna Kakehashi
Naomi Ishii
Min Gi
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference